Harvesting Health and Reaping Profits: The $2.2 Million Cure for Sickle-Cell Disease 

[I]n the period between late 2023 and early 2024, a groundbreaking development has emerged: the Federal Drug Authority (FDA) and the European Union (EU) approvals of a gene-editing therapy that has the potential to change the course of treatment of [Sickle Cell Disease] forever.